US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
ContextLogic Inc. - Class A Common Stock
(NQ:
LOGC
)
7.060
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ContextLogic Inc. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
Why LogicBio Therapeutics Shares Are Popping Off Today
↗
May 09, 2022
LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher by 63.48% at $0.81 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application,...
Via
Benzinga
LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric Trial
↗
May 09, 2022
Via
Benzinga
FDA Lifts Clinical Hold on LogicBio Therapeutics' IND for LB-001 in pediatric patients with Methylmalonic Acidemia
↗
May 09, 2022
The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on LogicBio Therapeutics’ (NASDAQ: LOGC) Investigational New Drug Application (IND) of its drug candidate LB-001 for pediatric...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 06, 2022
Via
Benzinga
80 Biggest Movers From Yesterday
↗
May 04, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 02, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
April 29, 2022
Good morning, trader! It's the beginning of the end as we break down all of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
LogicBio Therapeutics's Return On Capital Employed Insights
↗
March 10, 2022
According to Benzinga Pro data, during Q4, LogicBio Therapeutics (NASDAQ:LOGC) posted sales of $2.03 million. Earnings were up 11.02%, but LogicBio Therapeutics still reported an...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
February 28, 2022
Gainers Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5...
Via
Benzinga
71 Biggest Movers From Yesterday
↗
April 27, 2022
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More
↗
February 06, 2022
Biotech stocks managed to close the week with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid some big pharma earnings. The sector came...
Via
Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
↗
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
↗
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
↗
February 03, 2022
Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago...
Via
Benzinga
54 Biggest Movers From Yesterday
↗
February 03, 2022
Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50...
Via
Benzinga
Analyst Ratings For LogicBio Therapeutics
↗
February 02, 2022
Over the past 3 months, 4 analysts have published their opinion on LogicBio Therapeutics (NASDAQ:LOGC) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
February 02, 2022
During Wednesday's session, 18 companies made new 52-week lows. Noteable 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) is the largest company in terms of market...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
February 02, 2022
Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6...
Via
Benzinga
Why Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?
↗
February 02, 2022
The FDA has placed a clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with methylmalonic...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 02, 2022
Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
February 02, 2022
Good morning, investor! We're beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
↗
February 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) stock moved upwards by 20.4% to $1.06 during Thursday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
46 Biggest Movers From Yesterday
↗
December 16, 2021
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...
Via
Benzinga
Looking Into LogicBio Therapeutics's Return On Capital Employed
↗
November 15, 2021
According to data from Benzinga Pro, during Q3, LogicBio Therapeutics's (NASDAQ:LOGC) reported sales totaled $2.12 million. Despite a 2.71% increase in earnings, the company...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 19, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. The company's market cap stands at $684.2...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
↗
July 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
↗
July 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...
Via
Benzinga
Topics
Stocks
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
↗
July 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...
Via
Benzinga
Topics
Product Recall
< Previous
1
2
3
4
5
Next >
